Between November 1983 and August 1989, we performed single-lung transplantation for end-stage pulmonary fibrosis in 20 patients. Nine patients (45 percent) who survived for more than one year form the basis of this report. Before surgery, the nine survivors had severe restrictive lung disease, with a mean (+/- SD) vital capacity (VC) of 43 +/- 9 percent, a forced expiratory volume in one second (FEV1) of 50 +/- 9 percent, and a single-breath diffusing capacity (DLCO) of 36 +/- 9 percent of predicted values. One year after transplantation, the patients' VC had reached 69 +/- 10 percent, FEV1 79 +/- 15 percent, and DLCO 62 +/- 16 percent of predicted values. Relative perfusion to the transplanted lung rose from 63 +/- 14 percent (three days after surgery) to 77 +/- 7 percent within three months and stayed constant or increased slightly thereafter. Before surgery, despite supplemental oxygen at flow rates varying from 1 to 9 liters per minute, none of the patients could exercise beyond stage 1/2 (2.7 km [1.7 miles] per hour, 5 percent grade) on a modified Bruce treadmill-exercise protocol. All eight patients tested one year or more after transplantation achieved at least stage 1 (2.7 km [1.7 miles] per hour, 10 percent grade), and usually a higher stage, without supplemental oxygen. Arterial oxygen tension returned to normal values in most patients (87 +/- 13 mm Hg), and supplemental oxygen, which all patients required before surgery, was no longer needed by any patient after transplantation. We conclude that in carefully selected patients with end-stage pulmonary fibrosis, single-lung transplantation is an effective treatment.
Source Information
Department of Medicine, Toronto General Hospital, ON, Canada.
This article has been cited by other articles:
Corsico, A. G., D'Armini, A. M., Cerveri, I., Klersy, C., Ansaldo, E., Niniano, R., Gatto, E., Monterosso, C., Morsolini, M., Nicolardi, S., Tramontin, C., Pozzi, E., Vigano, M.
(2008). Long-term Outcome after Pulmonary Endarterectomy. Am. J. Respir. Crit. Care Med.
178: 419-424
[Abstract][Full Text]
King, T. E. Jr.
(2005). Clinical Advances in the Diagnosis and Therapy of the Interstitial Lung Diseases. Am. J. Respir. Crit. Care Med.
172: 268-279
[Abstract][Full Text]
Studer, S.M., Levy, R.D., McNeil, K., Orens, J.B.
(2004). Lung transplant outcomes: a review of survival, graft function, physiology, health-related quality of life and cost-effectiveness. Eur Respir J
24: 674-685
[Abstract][Full Text]
Beccaria, M., Luisetti, M., Rodi, G., Corsico, A., Zoia, M.C., Colato, S., Pochetti, P., Braschi, A., Pozzi, E., Cerveri, I.
(2004). Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis. Eur Respir J
23: 526-531
[Abstract][Full Text]
Collard, H. R., King, T. E. Jr
(2003). Demystifying Idiopathic Interstitial Pneumonia. Arch Intern Med
163: 17-29
[Abstract][Full Text]
Zoia, M C, D'Armini, A M, Beccaria, M, Corsico, A, Fulgoni, P, Klersy, C, Piovella, F, Vigano, M, Cerveri, I
(2002). Mid term effects of pulmonary thromboendarterectomy on clinical and cardiopulmonary function status. Thorax
57: 608-612
[Abstract][Full Text]
Hardoff, R., Steinmetz, A. P., Krausz, Y., Bar-Sever, Z., Liani, M., Kramer, M. R.
(2000). The Prognostic Value of Perfusion Lung Scintigraphy in Patients Who Underwent Single-Lung Transplantation for Emphysema and Pulmonary Fibrosis. JNM
41: 1771-1776
[Abstract][Full Text]
Meyers, B. F., Lynch, J. P., Trulock, E. P., Guthrie, T., Cooper, J. D., Patterson, G. A.
(2000). Single versus bilateral lung transplantation for idiopathic pulmonary fibrosisA ten-year institutional experience. J. Thorac. Cardiovasc. Surg.
120: 99-107
[Abstract][Full Text]
Arcasoy, S. M., Kotloff, R. M.
(1999). Lung Transplantation. NEJM
340: 1081-1091
[Full Text]
Seki, S., Flavahan, N. A., Smedira, N. G., Murray, P. A.
(1999). Superoxide anion scavengers restore NO-mediated pulmonary vasodilation after lung transplantation. Am. J. Physiol. Heart Circ. Physiol.
276: H42-H46
[Abstract][Full Text]
Yoshida, K., Flavahan, N. A., Horibe, M., Smedira, N. G., Murray, P. A.
(1999). Endothelial defect mediates attenuated vasorelaxant response to isoproterenol after lung transplantation. Am. J. Physiol. Heart Circ. Physiol.
276: H159-H166
[Abstract][Full Text]
Keller, C. A
(1998). The donor lung: conservation of a precious resource. Thorax
53: 506-513
[Full Text]
Brunsting, L. A., Lupinetti, F. M., Cascade, P. N., Becker, F. S., Daly, B. D., Martinez, F. J., Lynch, J. P., Whyte, R. I., Bove, E. L., Bolling, S. F., Orringer, M. B., Florn, R. D., Deeb, G. M.
(1994). Pulmonary function in single lung transplantation for chronic obstructive pulmonary disease. J. Thorac. Cardiovasc. Surg.
107: 1337-1345
[Abstract][Full Text]
(1990). SINGLE-LUNG TRANSPLANT SUCCESSFUL IN PULMONARY FIBROSIS. JWatch General
1990: 5-5
[Full Text]
Previous
